dedup-isc-ft-v107-score
float64 0.3
1
| uid
stringlengths 32
32
| text
stringlengths 1
17.9k
| paper_id
stringlengths 8
11
| original_image_filename
stringlengths 7
69
|
|---|---|---|---|---|
0.418395 | d37a99f7c654465da45ad251c29ec4ec | Trend in both-tests (home-test and laboratory confirmed test) as % of any with home tests (home-tests-only and both-tests): November 2021–April 2022. | PMC10076856 | fpubh-11-1058644-g0001.jpg |
0.473963 | 37c427c8d68d47c293c0e4aecf5c1479 | Percent of cases via home-tests-only (of all cases), by week and age category, November 2021–April 2022. | PMC10076856 | fpubh-11-1058644-g0002.jpg |
0.511541 | 9ba0489215d44b5b80e0597fb3e9659b | Trend in test type for COVID-19 cases January–April, 2022 relative to November/December 2021: adjusted odds ratios (aOR) and confidence intervals (Cl)a. aAdjusted odds ratios (aORs) are adjusted for age and county. As demonstrated in Table 1 and Figure 2, the number of home-tests was small in November/December 2021. Therefore, in estimating aORs, of trends above, combined November/December 2021 case numbers were used as the reference category. | PMC10076856 | fpubh-11-1058644-g0003.jpg |
0.469939 | b5ac96238fdb4b97a21963ca553409e3 | Multivariate logistic regression: adjusted odds ratios (aOR) and confidence intervals (Cl) for home-tests-only vs. laboratory-test-onlyb.bThe following variables adjusted in the model are not displayed above: month, county, gender missing, and some exposure sources (political rally/gathering, summer camp, and not reported). | PMC10076856 | fpubh-11-1058644-g0004.jpg |
0.53858 | bcf006e430114cf9b6ae419030c09437 | Chemical structures of compounds 1–9. | PMC10077343 | d3ra00720k-f1.jpg |
0.464527 | 00bbbac95b0b43a6abb870de43ddd06d | (A) Key 1H–1H COSY () and HMBC () correlations of 1–3, 5, 7. (B) (left) ORTEP of 1 with thermal ellipsoids shown at 30% probability. (right) Experimental ECD and calculated ECD spectra of 3. | PMC10077343 | d3ra00720k-f2.jpg |
0.471925 | 4565d0f270d8408baad9e7b7877cf33e | (A) Cytotoxicities of 1 and 2. (B) Molecular docking on EGFR: (a) Overlay docking positions of 1 (red), 2 (green), and afatinib (yellow) in the active site of EGFR (surface model). (b and c) The binding mode between EGFR and 1, 2, respectively. (C) IC50 values of EGFR inhibition for 1 and 2. | PMC10077343 | d3ra00720k-f3.jpg |
0.368949 | f707d99bdc904fc4b717162f5cb30c9b | GAT bar graph for normophonic and AdSD voices. The central horizontal line and the bottom and top edges of the boxes indicate the median, 25th, and 75th percentiles, respectively. The whiskers are indicative of extreme data points after the outlier removal. The individual stars show the outliers. | PMC10077958 | nihms-1879756-f0001.jpg |
0.43549 | c83f362091d14216acc55924002ac2e2 | GOT bar graph for normophonic and AdSD voices. The central horizontal line and the bottom and top edges of the boxes indicate the median, 25th, and 75th percentiles, respectively. The whiskers are indicative of extreme data points after the outlier removal. The individual stars show the outliers. | PMC10077958 | nihms-1879756-f0002.jpg |
0.457516 | f2bbd1ba97054aa8a9119ba859fcb957 | GAT distribution (in ms) for the true vocal folds (bottom panel) and false vocal folds (top panel). | PMC10077958 | nihms-1879756-f0003.jpg |
0.417617 | cadab24bf669467dab2b714401992a27 | GOT distribution (in ms) for the true vocal folds (bottom panel) and false vocal folds (top panel). | PMC10077958 | nihms-1879756-f0004.jpg |
0.431984 | 487ced4992b54c5880f1e8c5f326f6f8 | GAT values (in ms) for different vocalizations (x-axis) for the normophonic voices (panel (a)) and AdSD (panel (b)). The subject IDs are shown in the legend. | PMC10077958 | nihms-1879756-f0005.jpg |
0.532359 | acbe8c467f714a3eb4e8b17fccb5c56d | Trends in the China Human Development Index (CHDI) and its sub-indices: 1990–2018 | PMC10078081 | 11205_2023_3105_Fig1_HTML.jpg |
0.410037 | b8825d7720b04bf7b21e8ec322f7be1b | Spatial and temporal evolution of CHDI in 31 provinces of mainland China: 1990–2018 | PMC10078081 | 11205_2023_3105_Fig2_HTML.jpg |
0.382211 | b7cf952e40c34e43997ccb2d63fb8f49 | Average annual growth rates of China's CHDI and its sub-indices in different periods | PMC10078081 | 11205_2023_3105_Fig3_HTML.jpg |
0.434436 | 4002a6d7d5454f5c946954a7cdcaaac5 | OmpU forms two highly diverse phylogenetic clusters.(A) Sequence alignment of the ompU alleles from strains V. cholerae N16961 and GBE1114. (B) OmpU has diverged into two major phylogenetic clusters. Red arrow indicates the clinical allele from N16961. Green and purple shading represent Cluster 1 and 2 respectively. (C) Survival of V. cholerae mutant strains encoding representative ompU alleles in the presence of 0.4% whole bile. Despite the large genetic differences between the alleles, strain survival in bile leads to convergent phenotypes. Error bars represent the standard deviation of the mean from at least three (N≥3) independent replicates. Statistical comparisons were performed using one-way ANOVA analyses followed by a Dunnett’s multiple comparison test. All constructs were compared to the WT unless otherwise stated. *p<0.05, **p<0.01, ***p<0.001. | PMC10079234 | pgen.1010490.g001.jpg |
0.440602 | 01b9b4999f9a4829b8287167a9267a59 | Comparative visualization of domains within OmpU associated with bile resistant phenotypes.(A). Multiple sequence alignment of ompU alleles resistant and sensitive to whole bile. Conserved residues are indicated by dots and those absent are indicated by gray boxes. (B-E) Comparative architecture of OmpU domains associated with the bile resistant phenotype. Domains are color coded and visualized in OmpU N16961 and GBE1114. Top and slabbed view of (B, C) N16961 and (D, E) GBE1114, respectively. The identified domains are colored as follows: NTC (purple), L3R (orange), L4 (blue) and VAS (green). | PMC10079234 | pgen.1010490.g002.jpg |
0.430141 | 0a346520a81e410eb234cac77ff8fe59 | OmpU domain mutants exhibit differential resistance to 0.4% bile.(A) Immunoblot analysis of individual OmpU domain mutants. (B) Survival of individual and naturally occurring ompU domain combination mutants in the presence of 0.4% whole bile. (C) Immunoblot analysis of naturally occurring OmpU domain mutants. Error bars represent the standard deviation of the mean from at least three (N≥3) independent replicates. Statistical comparisons were performed using one-way ANOVA analyses followed by a Dunnett’s multiple comparison test. All constructs were compared to the WT unless otherwise stated. *p<0.05, **p<0.01, ***p<0.001. | PMC10079234 | pgen.1010490.g003.jpg |
0.482754 | 592421dc1679430fa944642be84c2ca4 | Role of protein domains in OmpU-associated phenotypes.Survival of V. cholerae N16961 ompU mutant strains in the presence of (A) 200ug P2, (B) polymyxin B (450UmL-1) and (C) organic acid (0.005X). Error bars represent the standard deviation of the mean from at least three (N≥3) independent replicates. Statistical comparisons were performed using one-way ANOVA analyses followed by a Dunnett’s multiple comparison test. All constructs were compared to the WT unless otherwise stated. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001. | PMC10079234 | pgen.1010490.g004.jpg |
0.522394 | bb654006d8f54693949355e72ef13d0a | Exploration of novel functions of OmpU.(A) Phenotypic microarrays of V. cholerae WT and ΔompU strains. Area under the curve (AUC) was calculated to determine the total growth of the strains under exposure to diverse antimicrobial compounds. Only compounds with greater than 2-fold decrease in AUC for ΔompU strain are shown. Red rectangles indicate antibiotics with clinical relevance. All arrays were performed in duplicate. (B, C) Survival of V. cholerae N16961 and ΔompU in the presence of varying concentrations of (B) oxytetracycline and (C) cinoxacin. (D) Survival of ompU alleles in 7.5μg/mL rifamycin SV. Error bars represent the standard deviation of the mean from at least three (N≥3) independent replicates. Statistical comparisons were performed using one-way ANOVA analyses followed by a Dunnett’s multiple comparison test. All constructs were compared to the WT unless otherwise stated. *p<0.05. N≥3, *p<0.05. | PMC10079234 | pgen.1010490.g005.jpg |
0.384826 | c71dd00f9f4741e6ad33357d09d5edb9 | Optimized design of closely-couple 8-members MIMO antenna. | PMC10079684 | 41598_2023_32364_Fig10_HTML.jpg |
0.437677 | bd5441d3d3564037aa6b53b5e760c566 | Detail dimension of Ant 5–8 (a) top, (b) ground structure. | PMC10079684 | 41598_2023_32364_Fig11_HTML.jpg |
0.471736 | 1f6963feb147411280f8b2666a3d36e3 | Detail dimensions of Ant 1–4 (a) top, and (e) ground structure. | PMC10079684 | 41598_2023_32364_Fig12_HTML.jpg |
0.460977 | 567dddae3e7144f7854d6bfb0b1150dd | Simulated S-parameter results (a) Ant 1, (b) Ant 5. | PMC10079684 | 41598_2023_32364_Fig13_HTML.jpg |
0.49677 | 65a8f85cc3e94467b5dbd65012a34fb1 | Simulated S-parameter parametric results (a) I12 variation, (b) I16 variation. | PMC10079684 | 41598_2023_32364_Fig14_HTML.jpg |
0.393258 | 86a8f58fecd54462a1b798ce63d22527 | The density of surface current (a) Ant 1, (b) Ant 5 at 3.45 GHz. | PMC10079684 | 41598_2023_32364_Fig15_HTML.jpg |
0.42953 | 478c4114a4884526957a45ced097783b | The proposed customized MIMO (M-shaped) antenna measured S-parameters (fabricated sample in enclosure). | PMC10079684 | 41598_2023_32364_Fig16_HTML.jpg |
0.463003 | 3d65b17689bf4e27996fec89eaeb6115 | Projected MIMO (M-shaped) antenna polar plot (a) E-plane, (b) H-plane at 3.65 GHz. | PMC10079684 | 41598_2023_32364_Fig17_HTML.jpg |
0.502821 | 82b2adb6815d43e58be340c5c2bc0a0e | Proposed two members MIMO (M-shaped) antenna total efficiency. | PMC10079684 | 41598_2023_32364_Fig18_HTML.jpg |
0.459091 | 0b0e41985cfd48d8965e2971d6cbe0f7 | (a) ECC and (b) Closs results of proposed 2-Members MIMO (M-shaped) antenna. | PMC10079684 | 41598_2023_32364_Fig19_HTML.jpg |
0.403319 | 28ca436f47b64fe0a9d73cdd3c2c6f11 | Optimized design of closely-couple 2-Member MIMO (M-shaped) antenna structure. | PMC10079684 | 41598_2023_32364_Fig1_HTML.jpg |
0.429514 | 6652652d3f994489a2b4d2a6de63cb91 | Design sample prototype of 8 Members MIMO (M-shaped) antenna (a) Front view, (b) Rear view. | PMC10079684 | 41598_2023_32364_Fig20_HTML.jpg |
0.448443 | 171ae827c3134fc1a6e5e3705911da44 | Proposed 8 Members MIMO antenna Measured S-Parameters (a) Ant 1, (b) Ant 5. | PMC10079684 | 41598_2023_32364_Fig21_HTML.jpg |
0.436778 | f06dc8b3426b49148135b180933aeb61 | Proposed 8 Members MIMO antenna Polar plot (a) Ant 1 E-plane, (b) Ant1 H-plane, (c) Ant 5 E-plane, (d) Ant 5 H-plane. | PMC10079684 | 41598_2023_32364_Fig22_HTML.jpg |
0.454234 | f83fc8fcf21a44ab866d4a201ca598f0 | Total efficiency of projected eight members MIMO antenna. | PMC10079684 | 41598_2023_32364_Fig23_HTML.jpg |
0.398579 | 8a3fc5fa62ae48768b6b82158e9a6e90 | Proposed 8 Members MIMO antenna ECC. | PMC10079684 | 41598_2023_32364_Fig24_HTML.jpg |
0.408124 | 84dd46a3185b4a68947bc3deb4433c67 | Proposed 8-Members Mobile frame-based MIMO antenna design (a) Pairs of eight members, (b) structure of mobile frame, (c) member one structure and dimension, (d) member five detailed structure (all dimensions are in mm). | PMC10079684 | 41598_2023_32364_Fig25_HTML.jpg |
0.446475 | 024d80b7d52044e49cad7f29b5ce8744 | Proposed 8 Members mobile frame-based MIMO antenna S-Parameters simulated results (a) Ant 1, (b) Ant 5. | PMC10079684 | 41598_2023_32364_Fig26_HTML.jpg |
0.405486 | 20dd4fb80b6c4b50b2c30973c4b5b652 | Proposed 8 Members mobile frame-based MIMO antenna 3D radiation patterns simulated results (a) Ant 1, (b) Ant 2, (c) Ant 5, (d) Ant 6. | PMC10079684 | 41598_2023_32364_Fig27_HTML.jpg |
0.515446 | 93d6b43dd65844e2a30d7870d4542869 | Proposed 8 Members mobile frame-based MIMO antenna total efficiency. | PMC10079684 | 41598_2023_32364_Fig28_HTML.jpg |
0.490455 | adbe11220dac43268def6702c48680e6 | Hand effect on the mobile framed-based MIMO antenna (a) front view, (b) back view. | PMC10079684 | 41598_2023_32364_Fig29_HTML.jpg |
0.464438 | c5499b4247af4625a96d89a6040108b9 | Evolution of MIMO antenna S-parameters. | PMC10079684 | 41598_2023_32364_Fig2_HTML.jpg |
0.493953 | 53257049d25c45b694954401a5553f40 | Hand effect on the mobile framed-based MIMO antenna simulated reflection and transmission coefficients. | PMC10079684 | 41598_2023_32364_Fig30_HTML.jpg |
0.520869 | 1516df5dc03443da9011ad28a88ce8d3 | Hand effect on the mobile framed-based MIMO (M-shaped) antenna simulated total efficiency. | PMC10079684 | 41598_2023_32364_Fig31_HTML.jpg |
0.464264 | de32e1c29b494fa4b165893652ec74da | AntI S-parameter varies as a function of I5. | PMC10079684 | 41598_2023_32364_Fig3_HTML.jpg |
0.478991 | 68676d32627f49d9a5349a055a9fd5cb | Matching passive circuit configuration of the MIMO (M-shaped) antenna. | PMC10079684 | 41598_2023_32364_Fig4_HTML.jpg |
0.473822 | c81464e783e04eae9e5caddb9ad5acca | Phase plot and S-parameter simulated results of the 3D model and matching circuit of AntI. | PMC10079684 | 41598_2023_32364_Fig5_HTML.jpg |
0.580923 | 8ef435cb01024f5f893bdd9250c83bf3 | Phase plot and S-parameter simulated results of the 3D model and matching circuit of AntII. | PMC10079684 | 41598_2023_32364_Fig6_HTML.jpg |
0.426437 | b036d9a866534c349e41d81900d9c69f | Pedobarography during standing—assessment of foot alignment, angles of abduction (right foot normal abduction, left foot adduction) [121] and above-normal angles of foot proportions (gamma angle—normal range 15–18° [122,123,124]), indicative of the metatarsus adductus (i.e., forefoot adduction). | PMC10094411 | ijerph-20-05403-g0A2.jpg |
0.4739 | 4bc00b32ccb549aab04678c37ae6402c | Results of pedobarographic examination of foot arches, the so-called arch index, AI (normal range: 21–28%) [125]: (a) measured during standing; (b) during walking—finding lack of contact in the lateral foot compartment (i.e., abnormal contact of the lateral compartment with the ground), which confirms the pes planovalgus diagnosis from the visual examination (photogrammetry). | PMC10094411 | ijerph-20-05403-g0A3.jpg |
0.470253 | ff269670d4d846fb8f1b5ee700d49a8d | Pedobarographic imaging: (a)during standing, (b) during walking—repeatable results were used for analysis of hindfoot, midfoot and forefoot: MH—medial hindfoot and LH—lateral hindfoot (normal range: the physiological tarsal valgus in individuals over 8 years of age of 5 degrees translates to increased MH pressure by 15% [126]); the result indicates above-normal pressure in the medial compartment (MH), confirming the finding of tarsal valgus in the course of pes planovalgus. MF—midfoot; reduced pressure, indicative of overpronation (pes planovalgus). M1–5 metatarsophalangeal joint metaplanes; increased pressures are observed at M2–M4 compared to M1 and M5, representing a transverse arch collapse. T1—first toe and T2–5—toes 2–5; result indicates abnormal participation of the toes in the support function. | PMC10094411 | ijerph-20-05403-g0A4.jpg |
0.415474 | 7b0db76587f8420a86575ea8711adcba | Pedobarographic imaging shows pressure forces during the respective phases of gait; the result indicates abnormal heel strike (delayed landing with midfoot and forefoot involvement [127,128]). The result was confirmed with time-lapse images shown in Figure A6. | PMC10094411 | ijerph-20-05403-g0A5.jpg |
0.44277 | 3e908ca20b14465bbdef15f43234f7c1 | Pedobarographic imaging showing time-lapse images of foot rollover; the result indicates forefoot involvement in stage 1 of foot rollover, without midfoot involvement, which is associated with overpronation characteristic of pes planovalgus. | PMC10094411 | ijerph-20-05403-g0A6.jpg |
0.516364 | f2237944db044683bd9a1fd285ddee77 | Pedobarographic imaging showing centre of pressure progression (the thinner red dashed line) in four diagnostic aspects: maximum pressure, average pressure, contact time, pressure over time. The result confirms abnormal heel strike (lack of heel eversion), lack of foot supination under full loading (the line runs too medially [129,130]) and significant forefoot overload (especially at MTP 2–3), together with chaotic lines indicating midfoot and forefoot instability. | PMC10094411 | ijerph-20-05403-g0A7.jpg |
0.40215 | 0c16b0782780442781f163af26b7e72b | LncRNA TCONS_00323213 inhibits myoblast proliferation. (A) TCONS_00323213 knockdown efficiency detection. (B) TCONS_00323213 overexpression efficiency detection. The PZW1 plasmid was used to construct the overexpression vector. (C) EdU staining assays after TCONS_00323213 knockdown. (D) EdU staining assays after TCONS_00323213 overexpression. Scale bar: 50 µm. (E,F) CCK-8 assays of PSCs suggested that TCONS_00323213 knockdown significantly promoted myoblast proliferation after transfection with ASO-3213-1 for 12, 24, 36, and 48 h compared with proliferation in the NC group (E), while TCONS_00323213 overexpression inhibited myoblast proliferation (F). Mean values ± SD, n = 3. Statistical significance was assessed by Student’s t-test. * p < 0.05, ** p < 0.01, and *** p < 0.001. | PMC10094759 | ijms-24-06773-g001.jpg |
0.414837 | eb324cd08a744e07be7efe43c4e4b853 | TCONS_00323213 promotes myoblast differentiation. (A) Western blot analysis of MyoD, MyoG, and MEF2C expression levels after TCONS_00323213 knockdown. (B) Western blot analysis of MyoD, MyoG, and MEF2C expression levels after TCONS_00323213 overexpression. The western blot results contained three biological replicates in each group. (C) In PSCs differentiated for 36 h, a knowckdown of TCONS_00323213 significantly decreased MyoG expression. (D) Immunofluorescence staining in PSCs differentiated for 36 h showed that TCONS_00323213 overexpression significantly increased the MyoG expression level. Mean values ± SD, n = 3. * p < 0.05, ** p < 0.01. ns indicates no significant difference. | PMC10094759 | ijms-24-06773-g002.jpg |
0.448558 | 9b922a53752945d18c555b9b76fdb309 | TCONS_00323213 physically interacts with PKNOX2. (A) A schematic representation of the RNA pull-down assays. (B) Location of the TCONS_00323213-3 mutant fragments. (C) Interactions between a series of TCONS_00323213 mutant fragments (TCONS_00323213-1, TCONS_00323213-2, TCONS_00323213-3, TCONS_00323213-4, and TCONS_00323213-5) were assessed by RNA pull-down and WB assays. (D) Schematic representation of the RIP assay. (E) RIP assays were performed to validate the interaction between TCONS_00323213 and PKNOX2. (F) qPCR analysis of RIP assay results shows that TCONS_00323213’s relative expression is normalized to GAPDH. (G) Localization detection of TCONS_00323213 and PKNOX2 in PSCs. The 18s was used as an internal reference for cytoplasmic localization, while U6 was used as an internal reference for nuclear localization. (H) Localization analysis of PKNOX2 expression in PSCs after knockdown of TCONS_00323213. Mean values ± SD, n = 3. * p < 0.05, *** p < 0.001. | PMC10094759 | ijms-24-06773-g003.jpg |
0.391055 | 8a9eeb745a1b4f7eac161c5e0b37fc08 | Role of PKNOX2 in the differentiation of PSCs. (A) Real-time PCR analysis of PKNOX2 expression in PSCs during the period of proliferation and differentiation. There was a 12 h interval between each period. (B) A screening assay of siRNAs targeting PKNOX2 showed that si-PKNOX2-2 had the highest interference efficiency. (C) The knockdown of PKNOX2 increased the mRNA levels of MyoG and MEF2C. (D) Overexpression vector effect testing. (E) Overexpression of PKNOX2 decreased the mRNA levels of MyoG and MEF2C. (F,G) Knockdown of PKNOX2 increased the protein levels of MyoG, MEF2C, and MyHC. (H,I) Overexpression of PKNOX2 decreased MyoG, MEF2C, and MyHC protein expression levels. (J) IF in PSCs differentiated for 36 h, showing that the MyHC expression level was significantly increased by PKNOX2 knockdown. (K) IF in PSCs differentiated for 36 h showing that PKNOX2 overexpression significantly decreased the MyHC expression level. Mean values ± SD, n = 3. * p < 0.05, ** p < 0.01. ns indicates no significant difference. | PMC10094759 | ijms-24-06773-g004.jpg |
0.435732 | 36f53393baac4b249d097ba17709b351 | CUT and Tag Analysis of PKNOX2. (A) PKNOX2 enrichment analysis. (B) PKNOX2 significant enrichment motif sequence. (C). Distribution of PKNOX2-enriched regions on the genome. (D) Venn diagram of PKNOX2-binding genes versus differentially expressed genes in PSCs with TCONS_00323213 knockdown. (E). KEGG pathway enrichment analysis of the 307 genes in panel (D). (F). GO enrichment analysis of the 307 genes in panel (D). The RNA-seq experiment had three biological replicates, and the CUT and Tag experiment had two biological replicates. | PMC10094759 | ijms-24-06773-g005.jpg |
0.489754 | 73b4abe504aa492390cf392904599cc7 | IGV visualization demonstrates the RNA-seq and CUT and Tag signatures of myogenic differentiation-related genes. (A) Enrichment signal of PKNOX2 on MyoG and differential expression of MyoG by RNA-Seq. (B) The enrichment signal of PKNOX2 on MYC and differential expression of MYC by RNA-Seq. (C) PKNOX2 overexpression reduced the luciferase activity of the wild-type MyoG promoter construct, and luciferase activity increased upon TCONS_00323213 overexpression after PKNOX2 and the MyoG promoter plasmid had been co-transfected with the MyoG promoter. (D) Overexpression of PKNOX2 does not affect the luciferase activity of the MyoG promoter mutant. Mean values ± SD, n = 3. ** p < 0.01. ns indicates no significant difference. | PMC10094759 | ijms-24-06773-g006.jpg |
0.419671 | 33203cc997874f5eb25714c71daa9729 | A schematic diagram depicting the functions of TCONS_00323213 during skeletal muscle satellite cell differentiation. In differentiating PSCs, TCONS_00323213 binds to PKNOX2 to relieve the inhibitory effect of PKNOX2 on MyoG, thereby increasing MyoG expression and promoting PSC differentiation. | PMC10094759 | ijms-24-06773-g007.jpg |
0.403924 | 4cc760d792794e38b7405fb1819ccc22 | (a) SEM, (b) TEM and (c) HRTEM of Fe-N-CNSs. (d) HAADF-STEM and corresponding elemental mapping images of Fe-N-CNSs. | PMC10095661 | molecules-28-02879-g001.jpg |
0.463895 | 1cd3872411ec45e5b3ede62b04cbd83a | (a) XRD patterns, (b) XPS surveys, (c) N 1s spectra, (d) Raman spectra, (e) The N2 adsorption-desorption isotherms and (f) the pore size distribution of N-CNSs, Fe-N-CNSs and Fe-N-C. | PMC10095661 | molecules-28-02879-g002.jpg |
0.406941 | 04846a6a6bdc4df298fa3b0996587b99 | (a) CV curves of Fe-N-CNSs in O2/N2 saturated electrolyte. (b) LSV curves of the synthesized materials and Pt/C. (c) E1/2 together with [email protected] V towards these materials. (d) LSV curves of Fe-N-CNSs at different rotational speeds and the K-L plots. (e) Methanol tolerance and (f) i-t curves of Fe-N-CNSs and Pt/C. | PMC10095661 | molecules-28-02879-g003.jpg |
0.448358 | e48216a1a3d34355a195e46097a96afd | (a) Schematic diagram of ZAB. (b) OCV of two ZABs. (c) The photograph of the LED panel powered by the Fe-N-CNSs-based ZAB. (d) Discharging LSV and power density curves, (e) discharge curves of two materials from 5 to 50 mA cm−2, and (f) the specific capacity of two ZABs. | PMC10095661 | molecules-28-02879-g004.jpg |
0.411017 | ae621bd56d964c1bb1825506d00d157d | The synthesis flow for Fe-N-CNSs. | PMC10095661 | molecules-28-02879-sch001.jpg |
0.414095 | 09a24f464adb44d397ece0df2bd39b77 | Large-scale synthesis and derivatization study (a–c). | PMC10095780 | molecules-28-03137-sch001.jpg |
0.476798 | 291a4758344a4a04895677242d6c22d2 | Radical-trapping experiment (a–c). | PMC10095780 | molecules-28-03137-sch002.jpg |
0.444202 | 436aff9b4f644b8291ba471112b7c4f3 | Proposed reaction mechanism. | PMC10095780 | molecules-28-03137-sch003.jpg |
0.491862 | 0da983feeb0c43b8934208fd6541fe70 | Detail of the specimen (Units: mm). | PMC10096117 | materials-16-02666-g001.jpg |
0.477342 | 9dea80751a7f403c815d148483f5d7fb | Setup of accelerated corrosion. (a) Setup device; (b) scene for the corrosion. | PMC10096117 | materials-16-02666-g002.jpg |
0.455886 | d747822be1db43d09679e8b116d600df | Loading instrument and detail device. (a) Loading instrument; (b) detail of device. | PMC10096117 | materials-16-02666-g003.jpg |
0.433347 | 24d298cbb19644718dc9ec3e3b098ab4 | Color comparison. | PMC10096117 | materials-16-02666-g004.jpg |
0.443645 | f7f72888be894e56a8b60df23653d5db | Discoloration border: (a) discoloration boundary; (b) illustration of chloride discoloration depth measurement. | PMC10096117 | materials-16-02666-g005.jpg |
0.399717 | eac04ff6d80040338e63026d0e747265 | Crack observation. | PMC10096117 | materials-16-02666-g006.jpg |
0.425622 | 0cfa035001dc492ea0b90792209b4a21 | Crack width for different days. | PMC10096117 | materials-16-02666-g007.jpg |
0.409689 | c4d7d37442ed4d828bca1c900d013137 | Maximum crack width. | PMC10096117 | materials-16-02666-g008.jpg |
0.395662 | d4b8e14e32f14147b5a085b60dee3e6d | Appearance of corroded rebar: (a) 0%; (b) 3%; (c) 6%; (d) 9%; (e) 12% and (f) 15%. | PMC10096117 | materials-16-02666-g009.jpg |
0.451728 | cfe8733de7404d9a96eaf20d22397d64 | AgNO3 colorimetric results: (a) 20 d; (b) 30 d; (c) 40 d; (d) 50 d. | PMC10096117 | materials-16-02666-g010.jpg |
0.391596 | 315c068f04d14f2a9c655584fe55af48 | Chloride penetration depth. | PMC10096117 | materials-16-02666-g011.jpg |
0.422719 | 96bc8ec8d4394d119a6200d0c445fea3 | Detail of the specimen pieces and gray level. (a) Specimen pieces; (b) gray level. | PMC10096117 | materials-16-02666-g012.jpg |
0.368192 | 495e268154bf46bc8e3b7f1d1f431c0e | Binary processing image. (a) PVA0; (b) PVA0.2; (c) PVA0.4; (d) PVA0.6. | PMC10096117 | materials-16-02666-g013.jpg |
0.441902 | d647f5179c6d415fb073137e731f25cf | Typical failure of specimens: (a) pull-out failure; (b) splitting-pull-out failure and (c) splitting failure. | PMC10096117 | materials-16-02666-g014.jpg |
0.489103 | c27b2eb2939044bcac3696f8d32104dc | Bond stress–slip curves for the specimens with different PVA volume contents: (a) 0% series; (b) 1% series; (c) 5% series; (d) 8% series; (e) 12% series; (f) 15% series. | PMC10096117 | materials-16-02666-g015a.jpg |
0.400732 | 4fd0c28ae75143dc859d52507ef280fd | Bond strength of specimens with different contents of PVA fibers. | PMC10096117 | materials-16-02666-g016.jpg |
0.416433 | 4c20738c0cb04f16b727c39436090bb5 | Crack width before and after pull-out test. | PMC10096117 | materials-16-02666-g017.jpg |
0.544487 | 1fcc2689f8174c2da6a782fe33606737 | Bond stress–slip curves for the specimens with different corrosion loss: (a) PVA0 series; (b) PVA0.2 series; (c) PVA0.4 series; (d) PVA0.6 series. | PMC10096117 | materials-16-02666-g018.jpg |
0.449771 | 8f56ea65535c4524a5454de94dcc6335 | Bond stress–slip curves for the specimens with different corrosion loss. (a) Bond strength; (b) slip corresponding to bond strength. | PMC10096117 | materials-16-02666-g019.jpg |
0.474707 | 31b7bc8ebe3f462bb38609d9725b8c74 | The number of journal articles published between 2000 and 2022 containing the phrase “plant endophyte compounds” and “plant endophyte metabolites” within the title, abstract, or as a keyword (data based on a search from PubMed, 14 January 2023). | PMC10096483 | molecules-28-03246-g001.jpg |
0.490497 | 17ca6ee3220d44deaeb0f4092694ae5a | The number of journal articles published between 2000 and 2022 containing the phrase “bryophyte endophyte compounds”, “liverwort endophyte compounds”, “moss endophyte compounds”, and “hornwort endophyte compounds” within the title, abstract, or as a keyword (data based on a search from PubMed, 14 January 2023). | PMC10096483 | molecules-28-03246-g002.jpg |
0.50715 | a54012ed3554424ea7f5517f71171e53 | Bryendophyte metabolites with antimicrobial and immunosuppressive properties. | PMC10096483 | molecules-28-03246-g003.jpg |
0.4384 | 8cd6ab82d9e444c0b5b85444a817d347 | Bryendophyte metabolites (7–15) with cytotoxic and anticancer activities. | PMC10096483 | molecules-28-03246-g004.jpg |
0.410752 | 83549a0484924db5a6a4de94e6bcf1dd | Bryendophyte metabolites (16–24) with cytotoxic and anticancer activities. | PMC10096483 | molecules-28-03246-g005.jpg |
0.492184 | 0e5028b563b240669a1b73f6b86f848c | N-containing compounds (25–27) and pimarane diterpenoids (28–33) with cytotoxic and anticancer activities. | PMC10096483 | molecules-28-03246-g006.jpg |
0.467137 | 6d5e31df7940428a87f57c51642ae7d8 | Bryendophyte metabolites (34–42) with allelopathic and anti-inflammatory activities. | PMC10096483 | molecules-28-03246-g007.jpg |
0.405477 | 11511cbc93de40da83b8d43e6daeb188 | Graphic representation of bryophyte and bryendophyte metabolites. | PMC10096483 | molecules-28-03246-g008.jpg |
0.409699 | e35f4d6f362c459aa1ce81a8d796ed4c | Shows the flow chart for the preparation of mullite whiskers. | PMC10097341 | nanomaterials-13-01143-g001.jpg |
0.407834 | c800ed4f32a44816a920a6b2bb87c478 | SEM images of mullite whiskers prepared from feedstock without rare earth oxides (a) and from feedstock with rare earth elements (b). | PMC10097341 | nanomaterials-13-01143-g002.jpg |
0.432234 | 6048f582c5cb43f2b8e5abb86762c144 | XPS of mullite whiskers after washing and drying. | PMC10097341 | nanomaterials-13-01143-g003.jpg |
0.417869 | eef04aee4b31421bbd5bbf0e947000f3 | SEM images of various special morphological structures of mullite whiskers: (a,b) Whisker twist; (c,d) whisker tip droplets; (e,f) the top angles of the whiskers; (g,h) secondary growth of whiskers; (i,j) stacking fault. | PMC10097341 | nanomaterials-13-01143-g004.jpg |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.